USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Johnson Matthey Davy Technologies Limited

USPTO PatentsView assignee record - 43 granted patents across 9 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07C (Acyclic OR Carbocyclic Compounds).

RSS updates for this company

The verdict

According to USPTO PatentsView, Johnson ranks #7,579 of 49,997 tracked US assignees by granted-patent volume, with 43 patents across 9 technology areas.

#7,579
of 49,997 US assignees by volume
Top 47%
by Innovation Score (36.4/100)
16.8
avg claims per patent
+108%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R7579 · Foreign Corporation #7,579 · 43 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-SMALL 43 grants
  • UPPER-Q #7,579/49,997
  • PHOTO-FINISH International…
  • CPC-NARROW C07C · 9 areas
  • INNOV-THIN 36.4/100
  • CLAIMS-RICH 16.8 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-SURGE +108% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: International Institute of Cancer Immunology, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Johnson’s 36.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Johnson

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Johnson's Innovation Score is 36.4/100 (top 47% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Johnson?

Each dot is one of Johnson’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Johnson’s own 16.8 claims/patent is ABOVE the 7.0 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Johnson vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 42.943.043.04343.043.043.1 5101520 Granted patents (volume) Avg claims / patent International Institute of Cancer Immunology, Inc. - 43, 10.3International Ins…Inveniam Capital Partners, Inc. - 43, 15.72Inveniam Capital…Japan Petroleum Exploration Co., Ltd. - 43, 6.6Japan Petroleum E…Jiangsu Xcmg Construction Machinery Research Institute Ltd. - 43, 7.05Jiangsu Xcmg Cons…KAI R&D Center Co., Ltd. - 43, 5.91KAI R&D CenterKarl Leibinger Medizintechnik GMBH & Co. KG - 43, 10.72Karl Leibinger Me…KEY Foundry Co., Ltd. - 43, 17.44KEY FoundryKito Corporation - 43, 6.28KitoJohnson Matthey Davy Technologies Limited - 43, 16.79Johnson Matthey D…
Johnson vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Johnson's grants concentrate

Johnson Matthey Davy Technologies Limited is a focused PatentsView assignee: 9 CPC subclasses with 74.4% of grants classified under C07C (Acyclic OR Carbocyclic Compounds). Peak complete grant year is 2020 (10 grants) versus a trough of 1 in 2015. By volume, Johnson sits between International Institute of Cancer Immunology, Inc. and Kito Corporation.

Johnson's three-year grant acceleration

From 2019–2021 to 2022–2024, Johnson Matthey Davy Technologies Limited moved from 23 to 9 grants (0.39x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

Who files at Johnson's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Johnson holds 43 patents at rank #7,579, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Johnson

By rank, the assignees closest to #7,579 in granted patent volume.

Leaders in C07C (Acyclic OR Carbocyclic Compounds)

Other assignees with the most granted patents in Johnson's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Johnson, neither rank-band nor same-CPC leaders (those blocks stay above). In C07C (Acyclic OR Carbocyclic Compounds), Johnson ranks #136 of 2,691 assignees by patent count in that subclass.

Johnson's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

36 Top 47% higher than 53% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

024681012 20152016201720182019202020212022202320242025 3
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Johnson Matthey Davy Technologies Limited patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 1 2.3%
2016 3 7.0%
2017 3 7.0%
2018 1 2.3%
2019 5 11.6%
2020 10 23.3%
2021 8 18.6%
2022 3 7.0%
2023 5 11.6%
2024 1 2.3%
2025partial year 3 7.0%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Johnson Matthey Davy Technologies Limited's patent record in context - here's where to go next.

  • Johnson Matthey Davy Technologies Limited's lead technology class is C07C (Acyclic OR Carbocyclic Compounds), 74.4% of its portfolio - see every assignee active in that class. Explore C07C
  • Ranked #7,579 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Johnson Matthey Davy Technologies Limited against International Institute of Cancer Immunology, Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 36.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.